Tadalafil 5mg
Sponsors
IlDong Pharmaceutical Co Ltd, Chong Kun Dang Pharmaceutical, University of Florence, Adrian Gaspar, Menoufia University
Conditions
BPH with Other Lower Urinary Tract SymptomsBenign Prostatic HyperplasiaChronic Prostatitis With Chronic Pelvic Pain SyndromeErectile DysfunctionErectile Dysfunction Following Radical ProstatectomyErectile Dysfunction Following Urethral SurgeryErectile Dysfunction With Diabetes MellitusIVF
Early Phase 1
Phase 2
Efficiency of Tadalafil for Management of Female Sexual Dysfunction
NCT05266651
Start: 2022-03-10End: 2022-05-31Target: 24Updated: 2022-03-04
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
RecruitingNCT05558007
Start: 2023-11-22End: 2025-01-31Target: 72Updated: 2024-10-22
Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction
RecruitingNCT06583590
Start: 2024-08-01End: 2025-12-01Target: 32Updated: 2024-12-03
Phase 3
The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
NCT02862483
Start: 2016-03-31End: 2017-03-31Target: 330Updated: 2016-08-12
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
CompletedNCT03246880
Start: 2015-09-30End: 2016-05-31Updated: 2017-08-11
Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes
RecruitingNCT06520839
Start: 2024-05-17End: 2024-12-31Target: 90Updated: 2024-07-25
Phase 4
Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction
CompletedNCT05446493
Start: 2019-04-01End: 2022-01-05Updated: 2022-07-06
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
NCT05494567
Start: 2021-11-08End: 2022-08-31Target: 60Updated: 2022-08-10
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
NCT05537272
Start: 2022-09-01End: 2023-09-01Target: 120Updated: 2023-02-22
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study
CompletedNCT06809205
Start: 2023-04-20End: 2024-08-30Updated: 2025-02-05
Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
RecruitingNCT07499804
Start: 2023-10-01End: 2026-04-30Target: 100Updated: 2026-03-30
Unknown Phase
Tadalafil Plus Tamsulosin for Male LUTS and ED
CompletedNCT04383093
Start: 2017-01-01End: 2018-01-01Updated: 2020-05-11
Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
CompletedNCT04446598
Start: 2017-03-13End: 2018-12-31Updated: 2020-06-25
Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia
NCT04577040
Start: 2020-10-01End: 2022-10-01Target: 400Updated: 2020-10-06
Impact of Tadalafil 5 mg on Post-micturition Dribble in Young-age Men With no/Mild Lower Urinary Tract Symptoms
NCT05146674
Start: 2022-01-01End: 2023-01-01Target: 80Updated: 2022-01-11
Use of a Phosphodiesterase Type 5 Inhibitor to Improve Anabolic Resistance in Older Adults
WithdrawnNCT05458232
Start: 2023-01-20End: 2023-01-20Updated: 2024-11-04
Management of OAB in Female Patients .
CompletedNCT06184334
Start: 2022-09-14End: 2023-12-01Updated: 2024-04-02
Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction
CompletedNCT06543628
Start: 2024-08-11End: 2025-03-03Updated: 2025-03-10
Tadalafil Daily Used Post Turp
CompletedNCT06788704
Start: 2021-05-01End: 2022-10-01Updated: 2025-01-28